Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon
暂无分享,去创建一个
L. Medeiros | J. Khoury | N. Pemmaraju | J. Jorgensen | Sa A. Wang | P. Aung | S. Loghavi | Wei Wang | Lianqun Qiu | Hong Fang | S. El Hussein | Xiaoqiong Wang | Carlos A. Torres Cabala | Wei Wang
[1] F. Jardin,et al. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape , 2020, Haematologica.
[2] M. Arcila,et al. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1 mutated acute myeloid leukemia. , 2020, Blood.
[3] H. Meyerson,et al. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation , 2020, Cytometry. Part B, Clinical cytometry.
[4] Yan-rong Liu,et al. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[5] Hannah C. Beird,et al. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era , 2019, Blood.
[6] M. Gobbi,et al. A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML , 2018, Blood.
[7] R. Kanagal-Shamanna,et al. Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria , 2018, Current Hematologic Malignancy Reports.
[8] M. Gobbi,et al. A blastic plasmacytoid dendritic cell neoplasm‐like phenotype identifies a subgroup of npm1‐mutated acute myeloid leukemia patients with worse prognosis , 2018, American journal of hematology.
[9] M. Teitell,et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. , 2004, American journal of clinical pathology.